ASTRAZEN.BOASTRAZEN.BOBSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+12.5%
5Y CAGR+6.4%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+12.5%/yr
vs +2.2%/yr prior
5Y CAGR
+6.4%/yr
Recent acceleration
Acceleration
+10.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$5.39B+19.6%
2024$4.51B+5.1%
2023$4.29B+13.3%
2022$3.78B+4.6%
2021$3.62B-8.4%
2020$3.95B-9.7%
2019$4.37B+25.9%
2018$3.47B+1.7%
2017$3.42B-2.7%
2016$3.51B-